
How to evaluate any peptide: a framework from evidence-based medicine
Five questions any patient can ask before considering a peptide — borrowed from the way physicians read a study.
TL;DR
- A simple five-question framework filters most peptide hype in under ten minutes.
- Animal evidence is not human evidence. Many compounds that look strong in mice do not hold up in people.
- The five questions sharpen the conversation you should be having with a licensed clinician.
What it is
Evidence-based medicine (in plain English: a method for weighing what the published research actually shows) is the tool physicians use to read a study and decide whether it changes practice. The same logic works for a curious patient. Think of it like checking a recipe before cooking it — you want to know who wrote it, whether it has been tested, and what could go wrong. Five questions cover most of the surface area. Used together, they separate signal from marketing.
How it works
The framework is a checklist, not a calculation. The first question is who paid for the research: an academic lab, a drug company, or a supplement seller. The second is whether the study was done in humans or only in animals or cells. The third is what was actually measured — a hard outcome like muscle mass, or a softer one like a self-reported feeling. The fourth is what side effects were observed and reported. The fifth is how the result stacks up against existing alternatives. Each question is a different reading of the same paper, the way a clinician would consult the NIH/PubMed record before recommending anything.
Who asks about it
People come to this topic when they hear about a peptide and want to know whether the buzz reflects real research. The framework is useful for podcast claims, clinic websites, and even articles like this one.
What the research says
The five-question framework comes directly from how peer-reviewed journals are read. A pre-clinical study (mouse, rat, cell culture) is treated as hypothesis. A small human trial is treated as preliminary signal. A large, randomized, placebo-controlled human trial is treated as practice-changing evidence. The peptide field has uneven evidence: GLP-1 medicines have very large human trials such as STEP and SURMOUNT, while many growth and healing peptides have only animal data or small open-label series, per the ClinicalTrials.gov record.
What to know before considering it
The framework does not replace a licensed clinician. It helps you bring better questions to the visit. Compounded peptides are not FDA-approved. Any decision to use a peptide should be made with a physician familiar with the evidence and the trade-offs.
The Halftime POV
We remove the mystery by handing readers the same checklist clinicians use. A curious patient who asks five questions is a better patient than one who asks none. The five questions are also a fair test of any clinic you might consider working with: if they cannot answer them clearly, that is information too.
Related reading:
- The four peptide families: a practical classification
- How peptides bind to receptors
- Longevity peptides vs supplements: comparing evidence
FAQ
Q: How can I tell if a peptide actually works? A: Ask five questions: who funded the research, was it tested in humans, what was measured, what side effects were observed, and how does it compare to alternatives.
Q: Are animal studies enough to trust a peptide? A: No. Animal studies suggest a direction but do not confirm a human result. Many compounds that look promising in mice fail in people.
Q: What is the most reliable peptide evidence source? A: Peer-reviewed PubMed-indexed journals and FDA documents are the most reliable. Influencer videos and clinic marketing are not evidence.
Disclaimer
This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.
Get updates
Halftime Health is launching soon. Join the waitlist for updates.
Sources
- National Institutes of Health. Health information. https://www.nih.gov/health-information
- US National Library of Medicine. ClinicalTrials.gov. https://clinicaltrials.gov/
- National Center for Biotechnology Information. PubMed. https://pubmed.ncbi.nlm.nih.gov/
Frequently asked questions
How can I tell if a peptide actually works?
Ask five questions: who funded the research, was it tested in humans, what was measured, what were the side effects, and how does the result compare to alternatives. Honest answers usually thin the field quickly.
Are animal studies enough to trust a peptide?
Animal studies suggest a direction but do not confirm a human result. Many compounds that look promising in mice fail in people. Use animal data as a starting question, not an answer.
What is the most reliable peptide evidence source?
Peer-reviewed PubMed-indexed journals and FDA documents are the most reliable. Influencer videos and clinic marketing are not evidence.
A licensed physician can build a protocol from your own labs.
Membership from $69/mo, including your onboarding panel. Each protocol is its own monthly subscription.




